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Summary Fractional ﬂow reserve (FFR) is emerging as a useful clinical tool for assessing
the functional signiﬁcance of coronary atherosclerosis. As opposed to anatomical approaches,
physiological measurements (particularly pressure-derived FFR) assess the function of the coro-
nary circulation and offer the possibility of ‘ad hoc’ treatment. The use of FFR is still limited
in France because there is no ﬁnancial support. The present review will focus on coronary
pressure-derived FFR.
© 2010 Elsevier Masson SAS. All rights reserved.
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Résumé La mesure de la réserve coronaire ou fractional ﬂow reserve (FFR) est un outil très
utile pour évaluer le caractère fonctionnel des lésions coronaires. Contrairement à l’approche
anatomique, l’évaluation physiologique (et notamment la FFR) permet de déterminer directe-
ment en salle de cathétérisme si une sténose est hémodynamiquement signiﬁcative. Cettecoronaire
percutanée ;
Revascularisation
sténose peut alors être traitée dans le même temps. L’utilisation de la FFR en France est
encore limitée en raison de l’absence de remboursement. Cet article est une revue des outils
de physiologie coronaire et s’intéresse plus particulièrement à la FFR.
© 2010 Elsevier Masson SAS. Tous droits réservés.
Abbreviations: CABG, coronary artery bypass graft; CFR, coronary ﬂow reserve; FFR, fractional ﬂow reserve; IMR, index of
microvascular resistance; LMCA, left main coronary artery; PCI, percutaneous coronary intervention; Pd, distal coronary
arterial pressure; Pv, coronary venous pressure; R, resistance of the coronary microvascular compartment; Tmn, mean transit time.
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ntroduction
he goal of any treatment is to improve patients’ progno-
is and/or symptoms. Accordingly, the goal of any diagnostic
ool is to guide decision-making, to apply optimal treatment
o individual patients. Any diagnostic tool not fulﬁlling these
equirements should not be used in patients. FFR is emerg-
ng as a useful technique for the assessment of coronary
rtery stenosis. FFR evaluates the functional signiﬁcance
f coronary artery stenosis and helps interventional car-
iologists with ‘on the spot’ decision-making [1,2]. This
s especially relevant when a coronary angiogram shows
ild-to-moderate coronary atheroma. The usefulness of FFR
s also further clinically validated in complex bifurcation
esions, ostial stenoses, multivessel disease and left main
tenoses [3]. As opposed to anatomical approaches, physi-
logical measurements (particularly pressure-derived FFR)
ssess the function of the coronary circulation and offer the
ossibility of ‘ad hoc’ treatment [4]. The use of this tool is
till limited in France because there is no ﬁnancial support.
he present review will focus on coronary pressure-derived
FR.
oronary circulation
o comprehend the concept of FFR, the coronary circu-
ation can be viewed as a two-compartment model. The
rst compartment consists of large epicardial vessels (> 400
icrons), which are also referred to as ‘conductance ves-
els’ because they have minimal resistance to blood ﬂow.
herefore, the pressure in the distal part of a healthy
uman coronary artery should be equal to central aor-
ic pressure. The second compartment consists of arteries
maller than 400 microns, or ‘resistive vessels’ (Fig. 1).
yocardial ﬂow is controlled predominantly by resistive ves-
els.
igure 1. Coronary circulation. As the epicardial vessels con-
ribute only a minimal fraction of the total vascular resistance there
s no signiﬁcant pressure drop along the conductance vessels. In con-
rast, passage through the resistive vessels produces a large drop in
ressure. CFR: coronary ﬂow reserve; FFR: fractional ﬂow reserve;
MR: index of microvascular resistance.
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hysiological indices of the coronary
irculation
n the next few paragraphs, we will discuss some of the rel-
vant indices of coronary physiology that can be used to
stimate coronary circulatory function as a guide to clinical
ecision-making. FFR is the best validated of all of these
hysiological indices. In the ﬁrst part of this section, we
ill brieﬂy describe the other indices before focusing on
FR.
oronary ﬂow reserve
FR is deﬁned as the ratio of hyperaemic blood ﬂow (Q
ax) to resting myocardial blood ﬂow (Q rest) (i. e. CFR =Q
ax/Q rest). The normal value for CFR is still not well
eﬁned and normal values differ from study to study [5,6].
here is some consensus of opinion, however, suggesting that
value > 4 should be considered as normal, which means
hat microvascular resistance can decrease by a factor of
[7]. As absolute myocardial ﬂow is not easy to deter-
ine, surrogate markers of ﬂow are commonly used, such
s ﬂow velocities assessed by the Doppler Wire (FloWire,
olcano Inc., Rancho Cordova, CA, USA) or Tmn assessed
y the PressureWire (Saint Jude Medical Systems Inc., Upp-
ala, Sweden). Regardless of the method used to measure
FR, this technique has several limitations: resting ﬂow is
ighly variable; there is considerable spatial heterogeneity
f ﬂow velocity distal to an epicardial stenosis; hyper-
emic ﬂow is directly dependent on systemic blood pressure;
he hyperaemic and resting measurements are performed
imultaneously not successively; and CFR is not speciﬁc
or an epicardial stenosis, as the CFR value depends on
oth epicardial vessels and microcirculation. When CFR is
ow, it is impossible to distinguish whether this value is
elated to an epicardial artery stenosis alone, microcircu-
atory dysfunction alone or a combination of both. Owing
o these limitations, CFR is not used routinely in clini-
al practice to assess the haemodynamic signiﬁcance of a
oronary stenosis and has limited value in clinical decision-
aking.
ndex of microvascular resistance
he resistance of a vascular system is deﬁned as the ratio
f the pressure gradient divided by the ﬂow across that par-
icular system. Accordingly, the resistance of the coronary
icrovascular compartment is equal to the ratio (Pd—Pv)/Q,
here Pd is distal coronary arterial pressure and Pv is coro-
ary venous pressure or right atrial pressure. In the coronary
irculation, Pv is often almost negligible. Fearon et al.
8] introduced the concept of IMR, considering that the
mn during maximal hyperaemia is inversely proportional
o hyperaemic ﬂow.
Therefore, during maximal hyperaemia, IMR = Pd/1/Tmn
Pd × Tmn. IMR is speciﬁc for the microcirculation and isimple to obtain, as Pd and Tmn can be obtained simultane-
usly with the PressureWire. This technique has been well
alidated in animals and was recently used in the setting
f acute coronary syndromes to predict clinical outcomes
nd assess the effect of treatment [5,7—12]. Nevertheless,
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a ratio of two pressures provided that these pressures are recorded
IMR is a novel index that needs further validation in clinical
studies.
Fractional ﬂow reserve
FFR is the ratio of maximal myocardial blood ﬂow depend-
ing on a stenotic artery to maximal myocardial blood ﬂow if
that same artery were to be normal. In other words, it is a
fraction of the maximal normal ﬂow, assuming that these
measurements are obtained when the microvasculature
resistance is minimal and constant (maximal hyperaemia)
[1,2].
FFR represents the extent to which maximal myocardial
blood ﬂow is limited by the presence of an epicardial steno-
sis. If FFR is 0.60, it means that maximal myocardial blood
ﬂow reaches only 60% of its normal value. Conversely, FFR
provides the interventionist with the exact extent to which
optimal stenting of the epicardial stenosis will increase max-
imal myocardial blood ﬂow. An FFR of 0.60 implies that
stenting the focal stenosis responsible for this abnormal FFR
should bring FFR to 1.0, which represents an increase in max-
imal myocardial blood ﬂow of 67%. In addition, FFR excludes
the confounding inﬂuence of the microcirculation, changes
in haemodynamics or contractility [1,13].
FFR is a ratio of two ﬂows. It has been shown, however,
that this ratio of two ﬂows can be derived from two pressures
(distal coronary pressure and aortic pressure), provided they
are both measured during maximal hyperaemia. The theo-
retical explanation of this relationship between hyperaemic
ﬂows and hyperaemic pressures is displayed in Fig. 2.
(
T
h
2
cplanation illustrating how a ratio of two ﬂows can be derived from
ng maximal hyperaemia.
ractional ﬂow reserve: practicalities
atheters
he use of diagnostic catheters is technically feasible [14].
owever, due to the higher levels of friction hampering wire
anipulation, the smaller internal calibre prejudicing pres-
ure measurements and the inability to perform ad hoc PCI
sing diagnostic catheters, the use of guiding catheters is
ecommended.
ires
wo pressure wire systems are available on the market for
easuring intracoronary pressure, namely the PressureWire
Saint Jude Medical Systems Inc., Uppsala, Sweden) and the
olcano WaveWire (Volcano Inc., Rancho Cordova, CA, USA).
he sensor is located 30mm from the tip, at the junction
etween the radiopaque and radiolucent portions. The last
enerations of these 0.014 inch wires have similar handling
haracteristics to most standard angioplasty guide wires.
yperaemia
o measure FFR, it is absolutely essential to achieve max-
mal vasodilatation of the two vascular compartments of
he coronary circulation, namely the conductance arteries
epicardial) and the resistance arteries (microvasculature).
he pharmacological agents most often used to induce
yperaemia are listed in Table 1 [15—17]. A bolus of
00mg isosorbide dinitrate (or any other form of intra-
oronary nitrate) abolishes any form of vasoconstriction
618
Table 1 Different vasodilators available for measuring
fractional ﬂow reserve.
Drug Delivery
Epicardial vasodilation
Isosorbide dinitrate ≥ 200g intracoronary
bolus, ≥ 30 s before
the ﬁrst measurements
Microvascular vasodilation
Adenosine or
adenosine triphosphate
140g/kg/min
intravenously
(preferably through a
central venous line)
Adenosine or
adenosine triphosphate
50g (to 150g)
intracoronary bolus
Papaverine Intracoronary delivery:
12—16 mg in the right
coronary artery; 16—20
mg in the left coronary
artery
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PNitroprusside 0.6g/kg intracoronary
bolus
f epicardial arteries. The pharmacological agents most
ften used to induce hyperaemia in resistance arteries are
denosine (via the intracoronary or intravenous routes) and
apaverine. An adenosine dose of 50g as an intracoronary
olus or 140g/kg/min as an intravenous infusion has been
emonstrated to induce hyperaemia similar to intracoronary
apaverine [15,16]. An example of a typical coronary pres-
ure tracing during the administration of intracoronary bolus
denosine is shown in Fig. 3.
nticoagulation
s soon as a device is advanced into the coronary tree, the
se of the same anticoagulation regimens as employed dur-
ng a PCI procedure are recommended: heparin adjusted to
eight, validated by a monitored activated coagulation time
f at least 250 s.
ractional ﬂow reserve: clinical
pplications
ntermediate lesions
he potential of angiography to evaluate the haemodynamic
everity of an intermediate lesion is limited. Moreover,
ngiographic assessment is often the only decision-making
odality for performance of angioplasty, especially in the
bsence of any sort of functional evaluation [18]. FFR
easurements correlate well with non-invasive assessment
f coronary artery disease. In patients with angiograph-
cally dubious stenoses, it has been shown that FFR is
ore accurate than exercise electrocardiography, myocar-
ial perfusion scintigraphy and stress echocardiography for
ssessing haemodynamic signiﬁcance [19]. Furthermore, the
esults of these non-invasive tests are often contradic-
ory, which renders appropriate clinical decision-making
v
m
r
d
dÉ. Puymirat et al.
ifﬁcult. In addition, the clinical outcome of patients in
hom PCI has been deferred, because the FFR indicated no
aemodynamically signiﬁcant stenosis, is very favourable.
n this population, the risk of death or myocardial infarc-
ion is approximately 1% per year and this risk is not
ecreased by PCI [20]. These results strongly support the
se of FFR measurements as a guide for decision-making
bout the need for revascularization in ‘intermediate’
esions.
eft main stem disease
he presence of a signiﬁcant stenosis in the LMCA is of crit-
cal prognostic importance and often determines the type
f treatment [13]. Therefore, the evaluation of haemo-
ynamic severity is essential and non-invasive testing is
ften non-contributive [4]. As mentioned before, the poten-
ial of coronary angiography to evaluate the haemodynamic
everity of a stenosis is limited, especially in the LMCA
21]. In addition, there are signiﬁcant interobserver vari-
tions in the assessment of LMCA lesions [22]. There may
e several reasons for the discrepancy between angio-
raphic and haemodynamic assessments of LMCA stenoses:
he catheter may overlap with the origin of the left
nterior descending and the left circumﬂex arteries, and
pillover of contrast medium and incomplete mixing of
lood and contrast medium in the proximal part of the
.
MCA may render the evaluation of an ostial lesion dif-
cult; the LMCA is generally short and, when present,
therosclerosis is often distributed diffusely, so that a nor-
al segment is lacking, which leads to an underestimation of
he ‘reference’ segment and thus to an underestimation of
MCA stenoses by both visual estimation and quantitative
oronary angiography; the myocardial mass that depends
n the LMCA is large, so the amount of blood that ﬂows
hrough it is great, and substantial trans-stenotic ﬂow, in
urn, induces large pressure gradients, especially during
yperaemia [23]. Finally, revascularization strategies based
olely upon an angiogram are often inappropriate in patients
ith an LMCA stenosis.
FFR can identify LMCA stenosis responsible for ischaemia.
everal studies showed that an FFR-guided strategy for
quivocal LMCA lesions is safe and related to a favourable
linical outcome [23—27]. Hamilos et al. assessed the
ong-term clinical outcome of 213 patients with an
ngiographically equivocal LMCA stenosis in whom the revas-
ularization strategy was based on FFR. When FFR was
0.80, patients were treated medically (n = 138) and when
FR was < 0.80, a CABG was performed (n = 75). The 5-year
urvival and event-free survival rates were similar in both
roups, supporting the use of FFR in patients with LMCA
isease [23].
ultivessel disease
atients with ‘multivessel disease’ actually represent a
ery heterogeneous population. In these patients, FFR
easurement has a major implication for the mode of
evascularization strategy (PCI vs CABG). Furthermore,
etermining which lesion(s) warrant stenting and which
o not can be difﬁcult in these patients, when using
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Figure 3. Fractional ﬂow reserve (FFR) in intermediate lesion. A) Intermediate stenosis of the middle left anterior descending estimated
at 45% by quantitative coronary angiography. B) Typical example of simultaneous aortic pressure (Pa) and distal coronary pressure (Pd)
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precordings at rest and during maximal steady state hyperaemia, as
infusion, the decrease in distal pressure is preceded by a transient
non-invasive imaging modalities. For example, myocardial
perfusion scintigraphy is limited in its ability to accu-
rately localize lesions responsible for ischaemia in these
patients [21,28]. Preliminary FFR-guided revascularization
strategies in patients with multivessel disease were very
encouraging [4]. A recent randomized multicentre study
(FAME: FFR versus Angiography for Multivessel Evaluation)
in 1000 patients showed that routine measurement of
FFR during PCI with drug-eluting stents in patients with
multivessel disease reduced the rate of the composite end-
point of death, myocardial infarction, re-PCI and CABG
at 1 year by approximately 30% and reduced mortal-
ity and myocardial infarction at 1 year by approximately
35%, compared with current angiography-guided strategy.
Moreover, the FFR-guided strategy reduces the number
of stents used, decreases the amount of contrast agent
used, does not prolong the procedure and is cost saving
[29,30].
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ved by an intracoronary bolus of adenosine. Soon after starting the
ase in aortic pressure.
yocardial infarction
fter a myocardial infarction, previously viable tissue is
artially replaced by scar tissue. Therefore, the total
ass of functional myocardium supplied by a given steno-
is in an infarct-related artery will tend to decrease
31]. By deﬁnition, hyperaemic ﬂow and thus hyperaemic
radient will both decrease as well. Assuming that the
orphology of the stenosis remains identical, FFR must
herefore increase. This does not mean that FFR under-
stimates lesion severity after myocardial infarction. It
imply illustrates the relationship that exists between ﬂow,
ressure gradient and myocardial mass, and, conversely,
llustrates that the mere morphology of a stenotic seg-
ent does not necessarily reﬂect its functional importance.
his principle is illustrated in Fig. 4. Recent data have
onﬁrmed that the hyperaemic myocardial resistance in
iable myocardium within the infarcted area remains normal
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both pressures electronically. After a long procedure, dif-igure 4. Fractional ﬂow reserve and myocardial infarction.
chematic representation of the relationship between fractional
ow reserve (FFR) and myocardial mass before and after myocardial
nfarction. DS: diameter stenosis.
32]. This further supports the application of the estab-
ished FFR cut-off value in the setting of partially infarcted
erritories. Earlier data had suggested that microvascular
unction was abnormal in regions remote from a recent
yocardial infarction [33,34]. However, more recent work,
aking into account distal coronary pressure, indicates
hat hyperaemic resistance is normal in these remote
egments [35]. These data support the use of FFR to
valuate stenoses remote from a recent myocardial infarc-
ion.
ifurcation lesions
ifurcation lesions are particularly difﬁcult to assess angio-
raphically because of the overlap orientation relative to
arent branch and radiological artefacts. Data supporting
he use of FFR in guiding PCI for bifurcation lesions are lim-
ted. Two recent studies by Koo et al. demonstrated: that
fter stenting, the ostium of the side branch often looks
pinched’ but is often overestimated by angiography (mea-
urement of FFR identiﬁes a minority of lesions that are
unctionally signiﬁcant) [36]; and a favourable outcome for
FR-guided side branch PCI strategy for bifurcation lesions.
ndeed, when kissing balloon dilation was performed only
n ostial stenoses with an FFR < 0.75, the FFR at 6 months
as > 0.75 in 95% of all cases [37].
oronary artery bypass graft lesions
n theory, the assessment of stenosis severity in CABGs
y FFR should not be different from FFR assessment of
ative vessels. At present, there are no clinical outcome
ata available regarding the use of FFR in graft stenosis.
herefore, FFR should be used with caution in bypass graft
tenosis. Nevertheless, in patients requiring CABG for mul-
ivessel revascularization, angiographic lesions of uncertain
igniﬁcance would beneﬁt from FFR, providing prognos-
ic information regarding potential of future bypass graft
atency. Botman et al. showed that the rate of occlu-
ion was approximately three times higher when the bypass
as placed on a native artery with a haemodynamically
on-signiﬁcant stenosis [38]. This study suggested that FFR
ould have serious implications for best long-term CABG out-
omes.
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ost stenting
ngiography alone is not a precise technique for detect-
ng local areas of incomplete stent expansion [39]. In
0—70% of stents that appear well deployed by angiogra-
hy, intravascular ultrasound imaging reveals a region of
he stent that is underexpanded compared with the remain-
er of the stent and with the reference segments [40,41].
ntravascular ultrasound is the gold standard for assess-
ng optimum stent deployment and its results are well
orrelated with the FFR. FFR has the advantage of being
asier to use but its results are more controversial. In a
mall single-centre study evaluating coil stents, an FFR
0.94 was identiﬁed as the appropriate threshold deﬁn-
ng optimal stent deployment [42]. This ﬁnding has not
een evaluated in a broader trial with current generation
tents.
ractical tips and tricks
e consistent in your fractional ﬂow
eserve-based decisions
t is important to be consistent in decision-making regard-
ng FFR. Traditionally, cardiologists have been trained to
ssess coronary stenosis by angiogram, and the use of FFR
equires a change in mindset. If, after measuring an FFR
f 0.9, you would decide to perform a PCI anyway or, con-
ersely, if after measuring an FFR of 0.7 you would decide
o leave a stenosis in a vessel supplying a large territory,
hen it is better not to perform the test at all. In addition,
nconsistencies in decision-making will weaken the enthusi-
sm of catheterization laboratory personnel and decrease
he operator’s credibility (keep in mind: ‘pressure never
ies’).
e careful with the sensor
ake care with the sensor that is located at the junction
etween the radiopaque and radiolucent part of the wire.
hin introducer needles
se thin introducer needles—but not if there is signiﬁcant
ackﬂow. The valve of the Y-connector should be tightly
losed.
qualization is essential
he aortic pressure transducer should be positioned at a
eight 5 cm below the patient’s sternum, which is estimated
o be the location of the aortic root. After calibration of
ortic pressure and the microchip of the PressureWire, the
ressureWire is advanced into the proximal part of the target
rtery, located at the tip of the guide, in order to equalizeerences may sometimes occur between aortic and coronary
ressures. Morphology of the distal pressure can cause the
ifference between true pressure gradient (ventricularized)
nd drift (exactly the same morphology).
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Avoid side-holes catheters
With side-holes catheters, the guiding pressure will result
in a pressure ‘somewhere in between’ coronary and aortic
pressure (side holes and end hole). Intracoronary adminis-
tration of drugs is unreliable.
Recognize ‘whipping’ of the wire
When the guide-wire sensor hits the coronary wall, an
increase in the pressure signal can be seen. Pull back (or
advance) the wire a few millimetres.
French register of fractional ﬂow reserve
Every year in France 260,000 coronary angiograms are per-
formed; however, measurement of FFR is conducted in only
2000 cases (< 1%). A national registry (R3F Register) was
established in March 2008 to evaluate the use of FFR in
France. So far, 1051 patients have been included in 25
centres. Follow-up is scheduled at 1, 6 and 12 months.
Objectives of this registry are to evaluate: the use of FFR
in France (indications, etc.); FFR-guided revascularization
strategies (compared with current angiography guided strat-
egy); and to report cost effectiveness.
Financial support: where is it?
At present, there is no ﬁnancial support for the use of FFR
in France. Discussions are underway with the Ministry of
Health and should reach an agreement regarding reimburse-
ment soon. FFR has demonstrated favourable outcomes in
patients with intermediate single-vessel stenoses, complex
bifurcation and ostial branch stenoses, multivessel coronary
artery disease, and left main stenoses. Furthermore, one
of the major arguments in favour of FFR use is a reduction
in cost [30,43,44]. In patients with an intermediate coro-
nary lesion and no prior functional evaluation, measuring
FFR can lead to signiﬁcant cost savings. Indeed, a 10—14%
reduction in cost was achieved compared with a strategy
of systematic PCI in patients with single- or multivessel
disease, respectively, and 39% compared with performing
ambulatory myocardial scintigraphy in patients with multi-
vessel disease [44].
Conclusion
The use of invasive coronary physiology in the catheteri-
zation laboratory is increasingly common. FFR introduces a
new concept for patients with suspected or known coronary
artery disease, as it combines physiological information,
anatomical information and the possibility of immediate
revascularization, if needed. With minimal experience, the
technique of FFR measurement is simple and safe. Clinical
outcome data from patients in whom the revascularization
strategy has been based on FFR measurements are very
encouraging. The current clinical evidence for FFR should
encourage cardiologists in France to use this tool in the
catheterization laboratory.
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